Business. FDA asks for a new clinical trial for 1 tx/month Aranesp dosing.
| Publicado en: | Nephrology News & Issues Vol. 20; no. 12; pp. 20 - 22 |
|---|---|
| Formato: | brief item Journal Article |
| Publicado: |
SLACK Incorporated
2006 Nov
|
| Acceso en línea: | Ver este registro en EBSCOhost |
| fields | @attributes: recordID: 1 pdfLink: plink: https://search.ebscohost.com/login.aspx?direct=true&db=ccm&AN=106216429&site=ehost-live header: @attributes: shortDbName: ccm uiTerm: 106216429 longDbName: CINAHL Complete uiTag: AN controlInfo: bkinfo: dissinfo: jinfo: jid: 08961263 1FVZ jtl: Nephrology News & Issues issn: 08961263 maglogo: N pubinfo: dt: 2006 Nov vid: 20 iid: 12 pid: 1693 pub: SLACK Incorporated place: Thorofare, New Jersey artinfo: ui: 106216429 106216429 2009368288 106216429 ppf: 20 ppct: 2 formats: tig: atl: Business. FDA asks for a new clinical trial for 1 tx/month Aranesp dosing. aug: sug: subj: Anemia, Iron Deficiency Drug Therapy Clinical Trials Economic Competition Erythropoietin Administration and Dosage Pharmaceutical Companies United States United States United States Food and Drug Administration pubtype: Academic Journal doctype: brief item Journal Article ougenre: Article ab: language: English refInfo: holdings: @attributes: islocal: N |
|---|